- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03065829
Self-Management Behaviors of Caregivers of the Chronically Critically Ill (ASSIST)
The Mediating Effects of Decentering on Self-Management Behaviors in Caregivers of Critically Chronically Ill Patients
For family members of chronically critically ill (CCI) patients, an ICU admission marks a significant milestone in the patient's illness trajectory that highlights the onset of end of-life issues and an abrupt need for family members to assume the caregiver role for the first time. Assuming the caregiver role can have devastating and longstanding health consequences for family members, which can impair their ability to sustain caregiving behaviors for a CCI patient. The unrelenting psychological distress perceived by caregivers of CCI patients is linked to significant reductions in their self-management and health outcomes.
The purpose of this study is to evaluate a theoretically-derived Adaptive SenSor-Based Intervention for Caregiver Self-ManagemenT (ASSIST) intervention compared to an attention control condition for first time caregivers of CCI patients discharged to an extended care facility. One group will be exposed to the ASSIST intervention and will wear the sensor-based technology for 30 days and receive a daily dose of MMT. Biophysical sensor data (blood pressure, heart-rate variability, pedometry, and actigraphy) will be continuously acquired and analyzed using anomaly detection and machine learning techniques to vary the dose intensity (number of doses per day) of the two components of ASSIST adding a real-time, adaptive feature to promote caregiver self-management. The other group will wear the sensor-based technology for 30 days but will not receive the daily dose of MMT. The investigators will randomly assign participants to each group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will conduct a randomized controlled trial to examine the ASSIST intervention compared to an attention control condition among 20 first time caregivers of CCI patients discharged to an extended care facility. The investigators will collect mixed methods data at baseline (T1) on Day 15 (T2) and Day 30 (T3) after subject enrollment to describe changes in proximal and distal outcomes. We have chosen our time points to capture neural and behavioral changes associated with the intervention.
The investigators aim to:
- Determine whether there are differences in the distal outcomes [psychological burden (anxiety, depression, caregiver burden, HRQoL), cardiovascular health (BP and HRV) and economic costs] between subjects who were exposed to ASSIST compared to those exposed to the attention control condition.
- Examine whether decentering, self-efficacy, decision-making, motivation, caregiver activation, and perceived stress mediate the relationship between exposure to a self-management condition (ASSIST vs. attention control) and the proximal (self-management) outcomes (stress reduction behaviors, sleep hygiene behaviors, and physical activity).
- Determine if social support and demographics (gender and age) moderate the proximal outcomes [emotional distress, sleep quality, and physical activity] or distal outcomes [psychological burden (anxiety, depression, caregiver burden, HRQoL), cardiovascular health (BP and HRV) and economic costs].
- Explore the differences in brain activation (structural and fMRI scans) and HPA function and stress response (hair cortisol, inflammation panel) between subjects exposed to ASSIST compared to those exposed to the attention control condition.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- University Hospitals Case Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 18 years or older
- recognized as the family member who will assume the caregiver role for a critically ill adult requiring at least 72 hours of mechanical ventilation and scheduled for a discharge to an extended care facility
- speak and comprehend English
Exclusion Criteria:
- currently practicing mindfulness-based interventions
- require psychotherapy or required psychotherapy within the last three months
- have a history of dementia or major neurological illness
- pregnant
- history of medical conditions or procedures that is contraindicated for fMRI scanning
- claustrophobia requiring anxiolytics or sedation
- expected to relocate from Northeast Ohio within two months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: ASSIST
The ASSIST intervention will deliver daily doses of MMT and vary dose intensity of all components each day based on the subject's biophysical data.
Across a 30-day period, the ASSIST intervention will capture and analyze data to deliver on-demand MMT, guided practices to promote sleep hygiene and physical activity.
Each day, subjects will receive at least one prompt to practice MMT (about 5 minutes at a time).
However, based on the subject's biophysical sensor data, subjects could receive a maximum of 5 alerts or prompts per day from the device to enhance stress reduction, sleep hygiene, or physical activity.
|
Wearable sensor technology delivering mindfulness meditation training (MMT) and health promotion (sleep hygiene and physical activity) .
|
EXPERIMENTAL: Attention-Control
This intervention exposes subjects to the wearable technology without the self-management components to minimize novelty effects.
Subjects assigned to this condition will wear the device for 30 days, which offers them an opportunity to experientially learn to self-monitor and employ self-regulatory skills by viewing the display biophysical data.
Subjects in this condition will not receive any prompts from the device.
|
Wearable sensor technology only viewing biophysical sensor data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Repeated Measures
Time Frame: Baseline to 30 days
|
ANCOVA Model (F-Statistic)
|
Baseline to 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Active Living Protocol (captured on wearable device)
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Sleep Activity
|
From Baseline to up to 30 days
|
Change in Daily Diary of Physical Activity (captured on wearable device)
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Physical Activity
|
From Baseline to up to 30 days
|
Change in Perceived Stress Scale
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Stress
|
From Baseline to up to 30 days
|
Change in PROMIS-29 Scale
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Anxiety and Depression
|
From Baseline to up to 30 days
|
Change in Zarits Burden Interview
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Burden
|
From Baseline to up to 30 days
|
Change in Health Behaviors Questionnaire
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Health Related Quality of Life
|
From Baseline to up to 30 days
|
Change in Heart Rate Variability (captured on wearable device)
Time Frame: From Baseline to up to 30 days
|
Measure of Caregiver Heart Rate Variablity
|
From Baseline to up to 30 days
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-15-11
- P30NR015326 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on ASSIST
-
King's College Hospital NHS TrustSt George's, University of LondonActive, not recruitingCongenital Diaphragmatic HerniaUnited Kingdom
-
University Hospital, AntwerpPhilips RespironicsTerminated
-
Vanderbilt University Medical CenterUniversity of Wisconsin, Madison; University of Illinois at Urbana-ChampaignActive, not recruitingAutism Spectrum Disorder | AutismUnited States
-
Children's Mercy Hospital Kansas CityCompletedRespiratory Insufficiency | Infant, Newborn, DiseaseUnited States
-
Temple UniversityRecruitingChildhood Apraxia of SpeechUnited States
-
Stephen BeedNova Scotia Health AuthorityNot yet recruitingCovid19 | Respiratory Failure
-
Mayo ClinicRecruiting
-
King's College LondonKing's College Hospital NHS TrustCompletedBronchopulmonary DysplasiaUnited Kingdom
-
West Park Healthcare CentreCompleted